Edap TMS SA (EDAP)
7.09
-0.06
(-0.84%)
USD |
NASDAQ |
Apr 23, 16:00
7.13
+0.04
(+0.56%)
After-Hours: 20:00
Edap TMS Cash from Investing (TTM): -4.703M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.703M |
| September 30, 2023 | 13.57M |
| June 30, 2023 | -4.131M |
| March 31, 2023 | -3.363M |
| December 31, 2022 | -2.508M |
| Date | Value |
|---|---|
| September 30, 2022 | -20.66M |
| June 30, 2022 | -2.432M |
| March 31, 2022 | -2.360M |
| December 31, 2021 | -1.938M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-20.66M
Minimum
Sep 2022
13.57M
Maximum
Sep 2023
-3.170M
Average
-2.508M
Median
Dec 2022
Cash from Investing (TTM) Benchmarks
| DBV Technologies SA | -0.808M |
| Biophytis SA | 0.3879M |
| Cellectis SA | -2.021M |
| Adaptimmune Therapeutics PLC | 176.54M |
| NuCana PLC | 3.594M |